HL RX is going to be the best group there; HL also has a solid power and utilities team based there. HW has a consumer team. Lazard is only MM and should not be compared to other LAZ offices. Also a few smaller regional shops to consider (Hennepin, TripleTree, Cherry Tree)

Culture is going to be better at these offices than most NYC counterparts. Have heard the HL team is a very chill office (shorts and t shirts), but quite sweaty so you'll work for it. 

 

What’s Lazard’s reputation been like the last 10 years? I heard they have lost some senior bankers there. Is the amount of talent at Lazard MPLS the same as a houlihan per se? What direction do you see those firms going in in the next 10 years?

 

For Laz the reputation of the MM group is quite a bit different. As I mentioned it's a completely different business model. They seem to do fine and compete with most MMs you've heard of. Would give HL the edge on talent, especially for RX

 

HL RX is a bunch of beauties. You will get worked like a dog though

 
Most Helpful

All grind on people and certain groups are frequent 90-100 hour weeks (Piper HCIT, Laz Food)

HL - best overall office in terms of deal quality, reputation, etc. Rx and Industrials.

Piper - largest office with some major teams (Medtech, HCIT, Industrials) that compete well in the MM and beyond (Medtech competes against BBs)

Laz MM - still have some very strong senior bankers, but lots of recent turnover and that office is bound to get wound down in the next few years based on who else is likely to retire. Laz parent has no interest or commitment to sub-$1B deals.

HW - competitive in consumer (mostly Food & Bev) and seems to be growing its presence, though not rapidly. Seems like a good long-term place to be.

BMO office is basically dead at this point. Will likely be shuttered within a year or two. Then you have boutiques after that.

 

I’ve heard good things from friends at TripleTree (Healthcare-focused). They get worked like a mule but have great exit ops (mid-top tier PE, UHG Corp Dev, UHG CorpFin, etc.). Their Avg. deal size is ~$700m with a few per year exceeding $2-3bn. They recently (in past 2 years) have had a $7-8bn transaction.

 

Not to put down TT in any way, but if you wanted UHG corp dev why would you not just join as an analyst? The whole selling point of that group is (or used to be) that you’re part a true executive fast-track program where you are promoted at an insane pace, and joining early would presumably give you a better shot being noticed by senior folks. Maybe this has changed in recent years though. 

 

IB Intern Monkey

I’ve heard good things from friends at TripleTree (Healthcare-focused). They get worked like a mule but have great exit ops (mid-top tier PE, UHG Corp Dev, UHG CorpFin, etc.). Their Avg. deal size is ~$700m with a few per year exceeding $2-3bn. They recently (in past 2 years) have had a $7-8bn transaction.

That's skewed heavily towards deals they are Co-advisors on. The ones they lead are lower, particularly on a median basis. They are a solid shop in HCIT, but have struggled with the downturn, similar to others (e.g., Blair, Piper). I've always felt comp was below street, but no idea how that's changed after Capital One. Talk about a weird relationship - TT gets literally nothing from Capital One, but provides a lot. I'd be shocked if MDs stuck around more than another year or two.

Also, UHG Corp Dev is atrocious. You work banker hours for half the pay. Not a place anyone should want to be unless you can't make it in IB.

 

Outside of laughing at the UNH exit opp comment, someone did give good perspective around a lot of MPLS IB groups being a grind across firms. Probably a testament to the strength of the groups across all the banks that have people sitting up there.

Healthcare groups in particular see a lot of activity. Minneapolis is underrated relative to all the large cap strategics that have a heavy presence in the metro (3M, UNH, Medtronic, CAH)

 

Sunt ad sint possimus sit. Cupiditate est sint quis eligendi. Reiciendis enim nisi ut omnis temporibus in culpa vero. Quia fugiat error necessitatibus minus.

Eos nemo soluta placeat omnis delectus iste. Velit odit suscipit voluptatem dignissimos cumque quam. Tempora animi natus maiores dolorum incidunt quidem. Voluptas dolorum dolores veniam accusamus accusamus voluptatem ut. Reprehenderit dignissimos quia sint molestiae aut. Blanditiis maxime nulla voluptatem commodi voluptatem aut voluptatem.

Officia nobis qui dolorem autem autem et voluptatibus. Aperiam voluptas vitae quis quibusdam. Quos provident tempora ut. Tempore consectetur maxime esse non officiis. Dolor placeat molestias laudantium autem esse. Unde porro eum eaque voluptas et optio ratione. Quae ducimus eveniet delectus possimus dolores nihil omnis.

Sed vel voluptatem magni laborum non. Quia aut dolorem aut commodi aut. Et recusandae ut consequatur quaerat eos et. At qui ut sit ut vero sint. Exercitationem et voluptatem nemo a dolor architecto occaecati.

 

Velit quia eos minima adipisci est repellendus. Est sint explicabo temporibus asperiores ducimus. Doloremque iure dolores sit est.

Non provident est aut molestiae minus aut voluptatem. Culpa magnam ut molestiae illo. Eos et voluptatem delectus aliquid. Non ut velit aperiam est. Illo occaecati magni nobis nulla dolores.

Nemo eos dignissimos aut qui non nulla occaecati. Magni reiciendis sed et perferendis. Reiciendis dolore culpa minima quibusdam eum.

Culpa consequuntur rerum aut rerum quam saepe quas. Nulla excepturi maiores consequatur molestiae. Nihil labore non deserunt id quia enim culpa. Assumenda rerum corrupti adipisci architecto ex praesentium.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”